Evolución clínica en un receptor de trasplante de hígado con la COVID-19: ¿Un efecto benéfico del tacrolimus?

Evolución clínica en un receptor de trasplante de hígado con la COVID-19: ¿Un efecto benéfico del tacrolimus?

Resumen: La enfermedad por coronavirus 2019 (COVID-19) es una enfermedad respiratoria seria causada por el virus SARS-CoV-2. Existe controversia respecto a si los inmunosupresores representan un factor de riesgo para desarrollar una enfermedad más grave.Aquí reportamos el desenlace clínico de tres m...

Full description

Bibliographic Details
Main Authors:	I. García-Juárez, A. Campos-Murguía, V.H. Tovar-Méndez, A. Gabutti, I. Ruiz
Format:	Article
Language:	Spanish
Published:	Elsevier 2020-10-01
Series:	Revista de Gastroenterología de México
Subjects:	COVID-19 SARS-CoV-2 liver transplantation immunosuppressors tacrolimus.
Online Access:	http://www.sciencedirect.com/science/article/pii/S0375090620301166

Similar Items

Microangiopatía trombótica en el trasplante renal, el tacrolimus como causante
by: Juan E. Rodriguez-Mori, et al.
Published: (2020-12-01)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against <i>Aspergillus</i> Species
by: Patrick Schwarz, et al.
Published: (2020-07-01)

Tacrolimus—why pharmacokinetics matter in the clinic
by: Lino Henkel, et al.
Published: (2023-08-01)

Tacrolimus as Antifungal Agent
by: Lyudmyla Antypenko, et al.
Published: (2019-12-01)

Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy
by: Kanika Sahni, et al.
Published: (2014-01-01)

Ciclosporina A e tacrolimus: uma revisão Cyclosporine A and tacrolimus: a review
by: Solange Cristina Garcia, et al.
Published: (2004-12-01)

Asociación entre los niveles de tacrolimus y la función renal temprana, rechazo agudo e infecciones tempranas en el trasplante renal, experiencia de un centro
by: Martín Gómez-Luján, et al.
Published: (2018-04-01)

Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food
by: Miłosz Miedziaszczyk, et al.
Published: (2022-10-01)

Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
by: Aureliusz Kolonko, et al.
Published: (2023-05-01)

Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus?
by: I. García-Juárez, et al.
Published: (2020-10-01)

Efficacy of Synthetic Peptide Corresponding to the ACTH-Like Sequence of Human Immunoglobulin G1 in Experimental Autoimmune Encephalomyelitis
by: Valery I. Turobov, et al.
Published: (2018-02-01)

Efficiency of tacrolimus therapy for perianal Crohn’s disease
by: B A Nanaeva, et al.
Published: (2015-06-01)

Formulation and Characterization of Self-Microemulsifying Drug Delivery System of Tacrolimus
by: Duaa J. Al-Tamimi, et al.
Published: (2021-06-01)

Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment
by: Howyda M. Ebrahim, et al.
Published: (2021-11-01)

Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus
by: Emily A. Bosselmann, et al.
Published: (2023-04-01)

Effectiveness and safety of topical tacrolimus in treatment of vitiligo
by: Ghasem Rahmatpour Rokni, et al.
Published: (2017-01-01)

When obstetrics–gynecology specialists need to call an ophthalmologist urgently: a case report
by: S. Masmejan, et al.
Published: (2021-10-01)

Leprosy detection rate in patients under immunosuppression for the treatment of dermatological, rheumatological, and gastroenterological diseases: a systematic review of the literature and meta-analysis
by: Daniel Holanda Barroso, et al.
Published: (2021-04-01)

Tacrolimus-induced cholestatic hepatotoxicity after renal transplantation: a case report
by: Fatemeh Pourrezagholi, et al.
Published: (2024-02-01)

Exfoliative Cheilitis in Childhood: A Successful Treatment with Tacrolimus
by: Emel Ulusoy, et al.
Published: (2023-03-01)

Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
by: Edward Chen, BA, et al.
Published: (2017-05-01)

Evaluation of Combination of Microneedling with Tacrolimus in the Treatment of Stable Vitiligo
by: Saurabh Sharma, et al.
Published: (2021-10-01)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
by: Arnaud Del Bello, et al.
Published: (2021-10-01)

Interacciones farmacológicas en trasplante
by: B. Rodrigo Orozco, Dr., et al.
Published: (2010-03-01)

Chemometrics assisted-electrochemical investigation of the binding and inhibition of calcineurin by tacrolimus: A combinatorial study
by: Ali R. Jalalvand
Published: (2021-12-01)

Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review
by: Andrea Sisti, et al.
Published: (2016-04-01)

A prospective study of correlation of blood levels of tacrolimus to graft function and adverse effect of tacrolimus in postrenal transplant patients
by: Krishna Asuri, et al.
Published: (2020-01-01)

A comparative study in treatment of childhood vitiligo 0.03% tacrolimus versus 0.03% tacrolimus and topical steroids
by: Anandan Venkatesan, et al.
Published: (2021-01-01)

Genetic factors underlying tacrolimus intolerance after liver transplantation
by: Yuan Liu, et al.
Published: (2022-09-01)

Tacrolimus for the Treatment of Ulcerative Colitis
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01)

Oral tacrolimus for severe recalcitrant eosinophilic cellulitis
by: Mirmovich Morvay, MD, et al.
Published: (2020-12-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Metabolomic Profiling of Mice with Tacrolimus-Induced Nephrotoxicity: Carnitine Deficiency in Renal Tissue
by: Sho Nishida, et al.
Published: (2024-02-01)

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
by: Shimojima Yasuhiro, et al.
Published: (2012-11-01)

Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties
by: Kang Luo, et al.
Published: (2019-06-01)

Hepatotoxic effect of chronic exposure of Tacrolimus in male Albino rats
by: Ali, I. Al-Ameedi
Published: (2016-06-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
by: Jin Won Kim, et al.
Published: (2021-11-01)

Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis
by: Raúl Vicente Olmedo-Martín, et al.

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)